2078
P. A. Koutentis, D. Lo Re
PAPER
MS (EI, 70 eV): m/z (%) = 414 (13) [M+ + 1], 413 (71) [M+], 307
IR (ATR): 3069w, 2926w, 1591w, 1566w, 1476s, 1449m, 1393s,
1317w, 1265w, 1242w, 1196w, 1130w, 1070w, 1061w, 1022w,
926w, 889m, 827m, 777s, 758w, 740w cm–1.
(4), 306 (28), 195 (12), 194 (72), 193 (7), 179 (9), 104 (9), 91 (100),
+
77 (20) [C6H5 ], 76 (17), 65 (25), 64 (12), 51 (9).
Anal. Calcd for C19H16IN3: C, 55.22; H, 3.90; N, 10.17. Found: C,
55.27; H, 3.89; N, 10.19.
MS (EI, 70 eV): m/z (%) = 365 (40) [M+ + 2], 364 (100) [M+ + 1],
363 (36) [M+], 362 (97) [M+ – 1], 283 (11) [M+ – Br], 259 (9), 180
(20), 179 (17), 178 (18), 152 (12), 151 (17), 103 (14), 77 (68), 51
(30), 50 (8).
1,3-Diphenyl-1,4-dihydro-1,2,4-benzotriazin-4-yl (1a): Typical
Procedure
UV/Vis (CH2Cl2): lmax (log e) = 277 (3.62), 322 (2.87), 376 (2.84),
434 (2.59), 498 (2.08).
DBU (7.5 mL, 0.05 mmol) and 5% Pd/C (17 mg, 1.6 mol%) were
added to a stirred soln of amidrazone 4a (143.5 mg, 0.5 mmol) in
dry CH2Cl2 (1 mL). The mixture was stirred at r.t. for 7 h until TLC
[t-BuOMe–hexane (1:4)] showed the absence of the starting mate-
rial and the presence of a new fast-running brown compound. The
solvent was evaporated under reduced pressure, and the residue was
purified dry flash chromatography [t-BuOMe–hexane (1:9)] to give
needle-shaped black crystals; yield: 121 mg (85%); mp 109–110 °C
(EtOH), (Lit.9 113–115 °C); g = 2.0033.
Anal. Calcd for C19H13BrN3: C, 62.83; H, 3.61; N, 11.57. Found: C,
62.85; H, 3.60; N, 11.52.
7-Iodo-1,3-diphenyl-1,4-dihydro-1,2,4-benzotriazin-4-yl (1e)
Brown crystals; yield: 166 mg (81%), mp 149–152 °C (cyclohex-
ane); g = 2.0026.
IR (ATR): 1684w, 1653w, 1591w, 1559m, 1539w, 1505w, 1489m,
1477s, 1456m, 1449m, 1392s, 1318m, 1267w, 1246w, 1193w,
1176w, 1069w, 1057w, 1024m, 883s, 828s, 780m, 774s, 739m
cm–1.
IR (ATR): 3061w, 3003w, 1585w, 1481s, 1450m, 1395s, 1317w,
1252w, 1206w, 1175w, 1082w, 1065w, 1024w, 984w, 916w, 880w,
841w, 785m, 750s cm–1.
MS (EI, 70 eV): m/z (%) = 411 (93) [M+ + 1], 410 (100) [M+], 334
(6), 307 (5), 284 (19), 283 (46) [M+ – I], 282 (23), 205 (7), 180 (14),
179 (15), 178 (12), 152 (10), 127 (5), 104 (11), 103 (13), 77 (44)
MS (EI, 70 eV): m/z (%) = 285 (44) [M+ + 1], 284 (100) [M+], 181
(16), 180 (15), 179 (21), 178 (14), 152 (12), 77 (58), 76 (22), 51
(30), 50 (15).
+
[C6H5 ], 51 (27).
UV/Vis (CH2Cl2): lmax (log e) = 271 (3.63), 322 (2.93), 372 (2.82),
429 (2.56), 494 (2.17).
UV/Vis (CH2Cl2): lmax (log e) = 280 (3.37), 323 (2.77), 377 (2.71),
438 (2.37), 481 inf (1.72).
1,3-Diphenyl-7-(trifluoromethyl)-1,4-dihydro-1,2,4-benzotriaz-
in-4-yl (1b)
Brown needles; yield: 141 mg (80%); mp 149–153 °C (cyclohex-
Anal. Calcd for C19H13IN3: C, 55.63; H, 3.19; N, 10.24. Found: C,
55.59; H, 3.07; N, 10.17.
ane); g = 2.0036.
7-Methyl-1,3-diphenyl-1,4-dihydro-1,2,4-benzotriazin-4-yl (1f)
Brown crystals, yield: 104 mg (70%); mp 160–163 °C (cyclohex-
ane); g = 2.0053.
IR (ATR): 1593w, 1506w, 1489m, 1452w, 1422m, 1395m, 1356m,
1337w, 1314m, 1281w, 1261m, 1248w, 1204w, 1150m, 1117s,
1063m, 1024w, 905m, 870m, 841m, 793w, 781m, 768m cm–1.
MS (EI, 70 eV): m/z (%) = 353 (M+ + 1, 33%), 352 (M+, 100), 249
IR (ATR): 3063w, 2920w, 1696w, 1684w, 1653w, 1592m, 1559w,
1539w, 1503m, 1490m, 1459w, 1452m, 1420w, 1394s, 1327m,
1279w, 1257w, 1170m, 1087w, 1067w, 1024m, 1002w, 929w,
917w, 862w, 849w, 844w, 803s, 780s, 759s, 712m cm–1.
+
(6), 247 (6), 226 (4), 180 (6), 103 (5), 77 (C6H5 , 26), 51 (10).
UV/Vis (CH2Cl2): lmax (log e) = 259 inf (4.04), 273 (4.21), 284 inf
(4.03), 323 (3.55), 373 (3.40), 431 (3.17), 495 (2.84).
MS (EI, 70 eV): m/z (%) = 299 (68%) [M+ + 1], 298 (100) [M+], 283
(7), 222 (10), 195 (16), 180 (10), 167 (5), 165 (7), 149 (40), 114 (5),
Anal. Calcd for C20H13F3N3: C, 68.18; H, 3.72; N, 11.93. Found: C,
68.27; H, 3.63; N, 11.89.
+
104 (4), 89 (10), 77 (23) [C6H5 ], 72 (7), 65 (4), 57 (5), 51 (12).
UV/Vis (CH2Cl2): lmax (log e) = 275 (4.21), 283 inf (4.10), 322
(3.55), 373 (3.35), 433 (2.95), 481 inf (1.58).
7-Chloro-1,3-diphenyl-1,4-dihydro-1,2,4-benzotriazin-4-yl (1c)
Brown crystals; yield: 130 mg (82%); mp 149–152 °C (cyclohex-
ane); g = 2.0030.
Anal. Calcd for C20H16N3: C, 80.51; H, 5.41; N, 14.08. Found: C,
80.50; H, 5.31; N, 13.92.
IR (ATR): 3069w, 2924w, 1614w, 1591w, 1474s, 1449w, 1394m,
1356w, 1317w, 1294w, 1265w, 1242w, 1192w, 1150w, 1092w,
1082w, 1024w, 897m, 846w, 829m, 779m cm–1.
MS (EI, 70 eV): m/z (%) = 321 (11) [M+ + 3], 320 (35) [M+ + 2],
319 (34) [M+ + 1], 318 (100) [M+], 283 (6) [M+ – Cl], 282 (6), 215
(10), 214 (5), 213 (9), 180 (12), 179 (11), 178 (15), 77 (49), 76 (11),
75 (15), 51 (23), 50 (6).
7-Methoxy-1,3-diphenyl-1,4-dihydro-1,2,4-benzotriazin-4-yl
(1g)
Brown crystals, yield: 113 mg (72%); mp 140–143 °C (Lit.29 144–
145 °C) (cyclohexane); g = 2.0032.
IR (ATR): 3061w, 3011w, 1603w, 1589w, 1578w, 1542w, 1501s,
1487s, 1466w, 1439w, 1418w, 1395m, 1348w, 1315w, 1263w,
1213m, 1163w, 1152w, 1125w, 1099w, 1065w, 1032m, 1003w,
989w, 917w, 851w, 831w, 795w, 773s, 733w, 716m cm–1.
MS (EI, 70 eV): m/z (%) = 315 (40) [M+ + 1], 314 (100) [M+], 271
(19), 168 (15), 106 (10), 77 (32), 63 (15).
UV/Vis (CH2Cl2): lmax (log e) = 275 (3.55), 322 (2.81), 374 (2.72),
436 (2.48), 480 inf (2.05).
Anal. Calcd for C19H13ClN3: C, 71.59; H, 4.11; N, 13.18. Found: C,
71.47; H, 4.03; N, 13.12.
UV/Vis (CH2Cl2): lmax (log e) = (3.15), 277 (3.42), 312 (2.37), 375
(2.45), 417 (2.16), 436 (2.26).
7-Bromo-1,3-diphenyl-1,4-dihydro-1,2,4-benzotriazin-4-yl (1d)
Brown crystals; yield: 171 mg (94%), mp 160–162 °C (Lit.4 176–
178 °C) (cyclohexane); g = 2.0030.
Supporting Information for this article is available online at
Synthesis 2010, No. 12, 2075–2079 © Thieme Stuttgart · New York